This inventor holds 72 USPTO granted patents and 15 published patent applications, plus 7 CIPO patents and 17 EPO patents, primarily in AAV Therapeutics (CPC class C12N). Top assignees: University of Massachusetts, Massachusetts Institute of Technology, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2008-2026.
Inventors with similar research interests:
Location History:
- Northboro, MA (US) (2008 - 2022)
- Northborough, MA (US) (2010 - 2023)
- Worcester, MA (US) (2023 - 2024)
Company Filing History:
72 out of 1,627 
10 out of 8,578 
10 out of 1,333 
Years Active: 2008-2026
Areas of Expertise:
Title: Innovator Spotlight: Phillip D Zamore Revolutionizing Gene Editing with rAAV-based Compositions
Introduction:
Phillip D Zamore, a renowned inventor in the field of genetic research, hails from Northboro, MA in the United States. With an impressive portfolio of 70 patents, Zamore's groundbreaking work has significantly advanced gene editing techniques.
Latest Patents:
One of Zamore's recent patents, "Compositions and methods for transient delivery of nucleases," focuses on the use of recombinant adeno-associated viruses to deliver nucleases to target cells. This innovative approach aims to minimize off-target genotoxicity associated with prolonged gene editing system expression in vivo.
Another notable invention is the "RAAV-based compositions and methods" patent which outlines isolated nucleic acids and rAAV-based compositions for treating genetic diseases like alpha-1 antitrypsin deficiency. Zamore's work in this area holds great promise for the future of genetic medicine.
Career Highlights:
Throughout his career, Zamore has made significant contributions while working at esteemed institutions such as the University of Massachusetts and the Whitehead Institute for Biomedical Research. His expertise and dedication have led to numerous breakthroughs in the field of genetic research.
Collaborations:
Zamore has had the privilege of collaborating with notable researchers in the field, including Gyorgy Hutvagner and Guangping Gao. These collaborations have enriched his research efforts and fostered a community of innovation in genetic studies.
Conclusion:
In conclusion, Phillip D Zamore's pioneering work in gene editing and genetic medicine has positioned him as a trailblazer in the field. Through his patented inventions and collaborative efforts, Zamore continues to push the boundaries of innovation, offering hope for the future of genetic research and personalized medicine.